Fidelity Investments
HITK

Fidelity Investments’s HI-TECH PHARMACAL INC HITK Stock Holding History

Fidelity Investments’s Portfolio HITK Stock Details HITK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-1,357,100
Closed -$58.9M – 2779
2013
Q4 		$58.9M Sell
1,357,100
-160,000
-11% -$6.92M 0.01% 1230
2013
Q3 		$65.5M Sell
1,517,100
-518,389
-25% -$19.8M 0.01% 1156
2013
Q2 		$67.6M Buy
+2,035,489
New +$67.7M 0.01% 1100

Other funds holding HITK

AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
LIM
Longfellow Investment Management Boston, Massachusetts $489M AUM 9.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments's HITK Position: Q1 2014 in Review

Fidelity Investments sold out of HI-TECH PHARMACAL INC (HITK) in Q1 2014, closing a stake of 1,357,100 shares — an estimated $58.9M sold.

Fidelity Investments first reported a position in HITK in Q2 2013 and held it in 3 quarters. The position peaked at $67.6M in Q2 2013. 108 funds tracked by Wall St. Rank hold HITK as of Q1 2014.

  • Fidelity Investments reported no remaining HI-TECH PHARMACAL INC position as of Q1 2014 after selling out during the quarter.
  • Fidelity Investments sold 1,357,100 HI-TECH PHARMACAL INC shares in Q1 2014, an estimated $58.9M.
  • Fidelity Investments first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 3 quarters.
  • Fidelity Investments's HI-TECH PHARMACAL INC position peaked at $67.6M in Q2 2013.
  • 108 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q1 2014.

Based on Fidelity Investments's 13F filing for Q1 2014, filed 15 May 2014.